Amylyx Pharmaceuticals
Cambridge
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $623.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:AMLX
- Website: amylyx.com
Industries & Categories
Biotechnology, Medical, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/amylyx-pharmaceuticals-21409 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.